XML 65 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' equity
 9 Months Ended
Sep. 30, 2025
Stockholders' Equity Note [Abstract]  
Stockholders' equity STOCKHOLDERS’ EQUITYCommon equity transactions
Common stock repurchase program
Under our common stock repurchase program authorized in December 2024, we may repurchase up to $500.0 million of our
common stock in the open market, in privately negotiated transactions, or otherwise through December 31, 2025.
During the three months ended March 31, 2025, we repurchased 2.2 million shares of common stock under this repurchase
program at an average price per share of $96.71.
No shares were repurchased during the three months ended June 30, and September 30, 2025. As of September 30, 2025,
the approximate value of shares that may yet be purchased under this program was $241.8 million.
ATM common stock offering program
In February 2024, we entered into an ATM common stock offering program that allows us to sell up to an aggregate of
$1.5 billion of our common stock.
During the nine months ended September 30, 2025, we had no activity under our ATM program. As of September 30, 2025,
the remaining aggregate amount available under our ATM program for future sales of common stock was $1.47 billion.
Dividends
During the three months ended March 31, 2025, we declared cash dividends on our common stock aggregating $228.3 million,
or $1.32 per share.
During the three months ended June 30, 2025, we declared cash dividends on our common stock aggregating $228.3 million,
or $1.32 per share.
During the three months ended September 30, 2025, we declared cash dividends on our common stock aggregating
$228.1 million, or $1.32 per share.
Accumulated other comprehensive loss
The change in accumulated other comprehensive loss attributable to Alexandria Real Estate Equities, Inc.’s stockholders
during the nine months ended September 30, 2025 was entirely due to net unrealized gains of $14.0 million on foreign currency
translation related to our operations primarily in Canada.
Common stock, preferred stock, and excess stock authorizations
Our charter authorizes the issuance of 400.0 million shares of common stock, of which 170.3 million shares were issued and
outstanding as of September 30, 2025. Our charter also authorizes the issuance of up to 100.0 million shares of preferred stock, none
of which were issued and outstanding as of September 30, 2025. In addition, 200.0 million shares of “excess stock” (as defined in our
charter) are authorized, none of which were issued and outstanding as of September 30, 2025.